Abstract:The serine-threonine protein kinase Akt is a direct downstream target of phosphatidylinositol 3-kinase (PI3-K). The PI3-K-generated phospholipids regulate Akt activity via directly binding to the Akt PH domain. The binding of PI3-K-generated phospholipids is critical to the relocalization of Akt to the plasma membrane, which plays an important role in the process of Akt activation. Activation of the PI3-K/Akt signaling pathway promotes cell survival. To elucidate the structural basis of the interaction of PI3-K-generated phospholipids with the Akt PH domain with the objective of carrying out structure-based drug design, we modeled the three-dimensional structure of the Akt PH domain. Comparative modeling-based methods were employed, and the modeled Akt structure was used in turn to construct structural models of Akt in complex with selected PIS-K-generated phospholipids using the computational docking approach. The model of the Akt PH domain consists of seven beta -strands forming two antiparallel beta -sheets capped by a C-terminal alpha -helix. The beta1-beta2, beta3-beta4, and beta6-beta7 loops form a positively charged pocket that can accommodate the PI3-K-generated phospholipids in a complementary fashion through specific hydrogen-bonding interactions. The residues Lys14, Arg25, Tyr38, Arg48, and Arg86 form the bottom of the binding pocket and specifically interact with the 3- and 4-phophate groups of the phospholipids, while residues Thr21 and Arg23 are situated at the wall of the binding pocket and bind to the l-phosphate group. The predicted binding mode is consistent with known site-directed mutagenesis data, which reveal that mutation of these crucial residues leads to the loss of Akt activity. Moreover, our model can be used to predict the binding affinity of PI3-K-generated phospholipids and rationalize the specificity of the Akt PH domain for PI(3,4)P2, as opposed to other phospholipids such as PI(3)P and PI(3,4,5)P3. Taken together, our modeling studies provide an improved understanding of the molecular interactions present between the Akt PH domain and the PIS-K-generated phospholipids, thereby providing a solid structural basis for the design of novel, high-affinity ligands useful in modulating the activity of Akt.

The Mechanism of ATP-Dependent Allosteric Protection of Akt Kinase Phosphorylation

Microsecond Molecular Dynamics Simulations Provide Insight into the ATP-competitive Inhibitor-Induced Allosteric Protection of Akt Kinase Phosphorylation.

Dual Roles of ATP-binding Site in Protein Kinases: Orthosteric Inhibition and Allosteric Regulation.

Theoretical Investigation of the Structural Characteristics in the Active State of Akt1 Kinase

The mechanism of PI3Kα activation at the atomic level

Molecular modeling and molecular dynamics simulation studies of the GSK3β/ATP/substrate complex: understanding the unique P+4 primed phosphorylation specificity for GSK3β substrates.

The Structural Basis of ATP As an Allosteric Modulator

I Kappa B Kinase Epsilon And Tank-Binding Kinase 1 Activate Akt By Direct Phosphorylation

The αC-β4 loop controls the allosteric cooperativity between nucleotide and substrate in the catalytic subunit of protein kinase A

The mechanism of allosteric inhibition of protein tyrosine phosphatase 1B.

Developments in Selective Small Molecule ATP-Competitive Inhibitors Targeting the Serine/Threonine Kinase Akt/PKB

Structural and Biochemical Insights into the Allosteric Activation Mechanism of AMP‐activated Protein Kinase

Multiple Functional Protein-Protein Interaction Interfaces Allosterically Regulate ATP-Binding in Cyclin-Dependent Kinase-1

Insight into the mechanism of allosteric activation of PI3Kα by oncoprotein K-Ras4B

Molecular modeling studies of the Akt PH domain and its interaction with phosphoinositides.

Akt Kinase Activation Mechanisms Revealed Using Protein Semisynthesis.

Phosphorylation-Dependent Inhibition of Akt1

The allosteric mechanism of mTOR activation can inform bitopic inhibitor optimization

Phosphorylation-dependent substrate selectivity of protein kinase B (AKT1)

Latent allosteric control of protein interactions by ATP-competitive kinase inhibitors